Mulkerrin MG - Search Results

1

Influence of histidine on the stability and physical properties of a fully human antibody in aqueous and solid forms.

Chen B, Bautista R, Yu K, Zapata GA, Mulkerrin MG, Chamow SM. Chen B, et al. Among authors: mulkerrin mg. Pharm Res. 2003 Dec;20(12):1952-60. doi: 10.1023/b:pham.0000008042.15988.c0. Pharm Res. 2003. PMID: 14725359

2

Enzymatic cleavage of a CD4 immunoadhesin generates crystallizable, biologically active Fd-like fragments.

Chamow SM, Peers DH, Byrn RA, Mulkerrin MG, Harris RJ, Wang WC, Bjorkman PJ, Capon DJ, Ashkenazi A. Chamow SM, et al. Among authors: mulkerrin mg. Biochemistry. 1990 Oct 23;29(42):9885-91. doi: 10.1021/bi00494a019. Biochemistry. 1990. PMID: 2125484

3

Validation of an HPLC method for the analysis of the charge heterogeneity of the recombinant monoclonal antibody IDEC-C2B8 after papain digestion.

Moorhouse KG, Nashabeh W, Deveney J, Bjork NS, Mulkerrin MG, Ryskamp T. Moorhouse KG, et al. Among authors: mulkerrin mg. J Pharm Biomed Anal. 1997 Dec;16(4):593-603. doi: 10.1016/s0731-7085(97)00178-7. J Pharm Biomed Anal. 1997. PMID: 9502155

4

The removal of pyroglutamic acid from monoclonal antibodies without denaturation of the protein chains.

Werner WE, Wu S, Mulkerrin M. Werner WE, et al. Anal Biochem. 2005 Jul 1;342(1):120-5. doi: 10.1016/j.ab.2005.04.012. Anal Biochem. 2005. PMID: 15958188

5

Rapid analytical tryptic mapping of a recombinant chimeric monoclonal antibody and method validation challenges.

Kannan K, Mulkerrin MG, Zhang M, Gray R, Steinharter T, Sewerin K, Baffi R, Harris R, Karunatilake C. Kannan K, et al. Among authors: mulkerrin mg. J Pharm Biomed Anal. 1997 Dec;16(4):631-40. doi: 10.1016/s0731-7085(97)00179-9. J Pharm Biomed Anal. 1997. PMID: 9502159

6

Hydroxylation of Lys residues reduces their susceptibility to digestion by trypsin and lysyl endopeptidase.

Molony MS, Quan C, Mulkerrin MG, Harris RJ. Molony MS, et al. Among authors: mulkerrin mg. Anal Biochem. 1998 Apr 10;258(1):136-7. doi: 10.1006/abio.1997.2513. Anal Biochem. 1998. PMID: 9527859 No abstract available.

7

Mambin, a potent glycoprotein IIb-IIIa antagonist and platelet aggregation inhibitor structurally related to the short neurotoxins.

McDowell RS, Dennis MS, Louie A, Shuster M, Mulkerrin MG, Lazarus RA. McDowell RS, et al. Among authors: mulkerrin mg. Biochemistry. 1992 May 26;31(20):4766-72. doi: 10.1021/bi00135a004. Biochemistry. 1992. PMID: 1591238

8

Purification and characterization of tissue plasminogen activator kringle-2 domain expressed in Escherichia coli.

Cleary S, Mulkerrin MG, Kelley RF. Cleary S, et al. Among authors: mulkerrin mg. Biochemistry. 1989 Feb 21;28(4):1884-91. doi: 10.1021/bi00430a068. Biochemistry. 1989. PMID: 2497771

9

Contribution to global protein stabilization of the N-capping box in human growth hormone.

Zhukovsky EA, Mulkerrin MG, Presta LG. Zhukovsky EA, et al. Among authors: mulkerrin mg. Biochemistry. 1994 Aug 23;33(33):9856-64. doi: 10.1021/bi00199a006. Biochemistry. 1994. PMID: 8060992

10

Contribution of domain interface residues to the stability of antibody CH3 domain homodimers.

Dall'Acqua W, Simon AL, Mulkerrin MG, Carter P. Dall'Acqua W, et al. Among authors: mulkerrin mg. Biochemistry. 1998 Jun 30;37(26):9266-73. doi: 10.1021/bi980270i. Biochemistry. 1998. PMID: 9649307

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters